ADGM vs XYL · $15.5M cap vs P/E 27, rev $4.46B
Adagio Medical Holdings, Inc Common Stock (ADGM) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Adagio Medical Holdings, Inc Common Stock (ADGM) is a medical devices company listed on NASDAQ.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported ADGM revenue for 2025-12-31 was $0. Net income was -$25.1M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ADGM currently screens at market cap $15.5M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
ADGM currently screens at market cap $15.5M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the ADGM and XYL stock pages for the full models.
Not investment advice.